|
|
 Role of Hepatitis C Virus (HCV) core antigen in improving blood transfusion safety in high prevalence, resource limited countries, a step forward  |
|
Potential Use of Antigen-Based Rapid Test for SARS-CoV-2 in Respiratory Specimens in Low- Resource Settings in Egypt for Symptomatic Patients and High-Risk Contacts. |
|
Safety and efficacy of autologous non- hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020 |
|
Severity-related Changes in Laboratory Results During Early Follow-up in COVID-19 Patients Treated with a Novel Cocktail of Stem Cells. |
|
Investigation of Transfusion Related Adverse events patterns in Fayoum University Hospitals, Egypt: hemovigilance Initiative. |
|
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Fayoum, Egypt. |
|
Evaluation of Pooling Strategy of SARS-CoV-2 RT-PCR in Limited Resources setting in Egypt at Low Prevalence. |
|
Extended Red Blood Cell Phenotyping among Regular Donors in Fayoum, Egypt. Red Blood Cell Inventory Plan. |
|
Frequency of Hepatitis B Surface Antigen and C Antibody
among Voluntary non Remunerated and Replacement
Donors in Fayoum, Egypt. Steps Towards 100% voluntary
non Remunerated Blood Dontation |
|
Elevated Cellular-microparticlesCoexpressing Endothelial and
Platelets Markers in Cerebro-vascular Ischemic Infarction
A Possible New Challenge for Early Diagnosis |
|
Combining serology and molecular typing of weak D role in
improving D typing strategy in Egypt |
|
The impact of fetal and maternal physiologic factors on umbilical
cord blood quality as a source of stem cells in Egyptian population |
|
Priority needs and wisdom strategy for blood transfusion
safety in developing low-resource countries
Abeer Mohamed Abdelrazik *, Ghada M. Ezzat Ahmed |
|
The Role of Hepatitis B core Antibody in improving Blood
Safety in Resource- Limited Countries
Study on Voluntary blood donors Fayoum, Egypt |
|
Study of red blood cell alloimmunization risk factors in
3 multiply transfused thalassemia patients: role in improving
4 thalassemia transfusion practice in Fayoum, Egypt |
Frequency of hepatitis B surface antigen and C antibody among voluntary non remunerated and replacement donors in Fayoum, Egypt. Steps towards 100% voluntary, non- remunerated blood donation. Egypt. J. Med. Lab. Sci. (2011)
Circulating Micro-Particles as potential hemostatic biomarkers for cerebrovascular ischemic infarction. The Journal of the Egyptian Society of Hematology and Research (2012); 8 (1): 21 - 26
Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt. Transfusion) 2013); 53: 2940 - 2944.
DOI:10.1111/trf.12100
Study of Cytotoxic T lymphocyte antigen 4 gene polymorphism A49G in Egyptian children with idiopathic thrombocytopenic purpura. Life Science Journal (2013); 10:3242 - 3246
The impact of fetal and maternal physiologic factors on umbilical cord blood quality as a source of stem cells in Egyptian population. Transfusion (2015); 55: 2882 - 2889. DOI:10.1111/trf.13258
The role of hepatitis B core antibody testing in improving blood safety in resource-limited countries study on voluntary blood donors Fayoum. J. Blood Disord. Transfusfusion (2015); 6: 315. DOI:10.4172/2155-9864.1000315
Priority needs and wisdom strategy for blood transfusion safety in developing low resource countries. Transfus. Apheresis Sci. (2016); 54:147 - 149.
DOI:10.1016/j.transci.2015.12.003
Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt. Transfusion (2016); 56: 2303 - 2307. DOI: 10.1111/trf.13695
Role of Hepatitis C Virus (HCV) core antigen in improving blood transfusion safety in high prevalence, resource limited countries, a step forward. Transfus. Apher. Sci. (2018); 57(4):566 - 568. DOI: 10.1016/j.transci.2018.06.006
A study of transfusion related adverse events in Fayoum University Hospitals, Egypt: Hemovigilence initiative: PB2446. HemaSphere (2019); 3 (S1):1083. DOI: 10.1097/01.HS9.0000568244.62280.16
Potential Use of antigen-based rapid test for SARS-CoV-2 in respiratory specimens in low- resource settings in Egypt for symptomatic patients and high-risk contacts. Laboratory Medicine (2020); 52 (2): e46 - e49.
DOI: 10.1093/labmed/lmaa104
Severity-related changes in laboratory results during early follow-up in COVID-19 patients treated with a novel cocktail of stem cell. Clinical Medicine Research (2021); 10 (4):133 - 141. DOI:10.11648/j.cmr.20211004.15
Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in Covid-19 patients. A Randomized clinical trial, Abu Dhabi (2020). Trasl. Med. Commun. (2021); 6 (1): 25. DOI: 10.1186/s41231-021-00101-5
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Fayoum, Egypt. Egyptian journal of medical research (EJMR)- Beni- Suef University. 10.21608/EJMR.2023.166111.1274
Evaluation of Pooling Strategy of SARS-CoV-2 RT-PCR in Limited Resources setting in Egypt at Low Prevalence. Comp Clin Path. 2023;32(3):375-381. doi: 10.1007/s00580-023-03445-6. Epub 2023 Feb 8. PMID: 36778967; PMCID: PMC9906572.
Extended Red Blood Cell Phenotyping among Regular Donors in Fayoum, Egypt. Red Blood Cell Inventory Plan. Egyptian Journal of Haematology 48(1):p 9-12, January-March 2023. | DOI: 10.4103/ejh.ejh_7_23
|